Title - combining parasite and vector components for development of a leishmania vaccine
Ended Definitive Contract Awarded
- Contract number
- HHSN272201600036C
- Awardee
-
PAI Life Sciences Inc. UEI MSMLUCM9DRT6
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $444,428
Award facts
- Opportunity
-
- PHS20161 Solicitation number
- A Low Cost Integrated Method for Isolation of M. Tuberculosis DNA from Raw Sputum Award Notice · Posted Jul 2, 2015
- Contract value 100% obligated
- $444,428.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 11 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Seattle, WA 98102, USA
Award details come from SAM.gov/FPDS.
About this award
This is a $444,428 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to PAI Life Sciences Inc., a self-certified small disadvantaged business. The contract is for the development of a Leishmania vaccine, combining parasite and vector components. This contract was designated as a total small business set-aside. PAI Life Sciences has a history of securing federal contracts and grants, particularly from NIAID, for the development of vaccines and adjuvants targeting infectious diseases. The company has previously received contracts for the development of late-stage adjuvant mimics and a prophylactic vaccine against onchocerciasis, as well as grants for the development of vaccines against urogenital schistosomiasis and COVID-19. This contract aligns with NIAID's broader program to advance the development of vaccines against neglected tropical diseases and emerging infectious threats.
Quick answers
Who was awarded contract HHSN272201600036C?
HHSN272201600036C was awarded to PAI Life Sciences Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 29, 2016.
How much is contract HHSN272201600036C worth?
The government has obligated $444,428 on HHSN272201600036C.
Was contract HHSN272201600036C competed?
The extent of competition for HHSN272201600036C was full and open competition after exclusion of sources. The government received 11 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award